NittoBest Corporation (TYO:2877)
Japan · Delayed Price · Currency is JPY 746.00
-2.00 (-0.27%)
Feb 16, 2026, 3:30 PM JST
NittoBest Revenue
NittoBest had revenue of 15.40B JPY in the quarter ending December 31, 2025, with 1.96% growth. This brings the company's revenue in the last twelve months to 57.10B, up 2.99% year-over-year. In the fiscal year ending March 31, 2025, NittoBest had annual revenue of 55.86B with 2.93% growth.
Revenue (ttm)
57.10B
Revenue Growth
+2.99%
P/S Ratio
0.16
Revenue / Employee
31.03M
Employees
1,840
Market Cap
9.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 55.86B | 1.59B | 2.93% |
| Mar 31, 2024 | 54.27B | 2.39B | 4.61% |
| Mar 31, 2023 | 51.88B | 2.13B | 4.29% |
| Mar 31, 2022 | 49.75B | 849.00M | 1.74% |
| Mar 31, 2021 | 48.90B | -5.36B | -9.89% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ahjikan | 51.00B |
| Nichiwa Sangyo | 45.90B |
| Hayashikane Sangyo | 45.24B |
| Yokohama Maruuo | 39.88B |
| AFC-HD AMS Life Science | 33.01B |
| Takizawa Ham | 26.88B |
| Wakou Shokuhin | 16.94B |
| PIETRO | 11.87B |